In this issue:
- Temporal trends in lifetime risk of AF and its complications
- Semaglutide in patients with obesity-related heart failure and type 2 diabetes
- Cardiac sarcoidosis in middle-aged adults with high-grade atrioventricular block
- Use of deep learning to estimate cardiovascular risk from chest radiographs
- 12 months of ticagrelor ± aspirin after PCI
- Bleeding risk in patients with AF using diltiazem with apixaban or rivaroxaban
- Direct oral anticoagulants for stroke prevention in patients with device-detected AF
- Long COVID and cardiovascular disease
- Invasive vs conservative management of older patients with NSTEMI
- Patterns of AF recurrence after catheter ablation